Nail pigmentation associated with zidovudine: a review and report of a case.
Zidovudine has become the standard therapy for patients with AIDS and for asymptomatic HIV infected patients with low helper-T-cell levels. As experience with the drug has grown, knowledge of the range of side effects has increased. We describe progressive pigmentation of finger and toe nails in a white patient due to zidovudine therapy, a phenomenon not often described. Nail pigmentation occurs primarily in black patients. It appears to be reversible and relatively dose dependent. The mechanism responsible for the discoloration is unknown. It is important to alert patients to this side effect and to prevent unnecessary investigations and treatment for other diagnoses, such as cyanosis.
Rahav
G
G
Department of Clinical Microbiology, Hadassah Medical School, Jerusalem, Israel.
Maayan
S
S
D000328:Adult; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009260:Nail Diseases / Q000139:chemically induced*; D010859:Pigmentation Disorders / Q000139:chemically induced*; D015215:Zidovudine / Q000009:adverse effects*
D015215:Zidovudine